A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential

Sci Rep. 2016 Nov 25:6:36349. doi: 10.1038/srep36349.

Abstract

Malignant mesothelioma (MM) is an aggressive serosal tumor associated with asbestos exposure. We previously demonstrated that mesothelial cells differentiate into cells of different mesenchymal lineages and hypothesize that osseous tissue observed in a subset of MM patients is due to local differentiation of MM cells. In this study, the capacity of human and mouse MM cells to differentiate into osteoblast-like cells was determined in vitro using a functional model of bone nodule formation and in vivo using an established model of MM. Human and murine MM cell lines cultured in osteogenic medium expressed alkaline phosphatase and formed mineralized bone-like nodules. Several human and mouse MM cell lines also expressed a number of osteoblast phenotype markers, including runt-related transcription factor 2 (RUNX2), osteopontin, osteonectin and bone sialoprotein mRNA and protein. Histological analysis of murine MM tumors identified areas of ossification within the tumor, similar to those observed in human MM biopsies. These data demonstrate the ability of MM to differentiate into another mesenchymal cell type and suggest that MM cells may contribute to the formation of the heterologous elements observed in MM tumors.

MeSH terms

  • Adult
  • Alkaline Phosphatase / metabolism
  • Animals
  • Biomarkers / metabolism*
  • Cell Differentiation
  • Cell Line, Tumor
  • Core Binding Factor Alpha 1 Subunit / metabolism
  • Dexamethasone / pharmacology
  • Dexamethasone / therapeutic use
  • Female
  • Humans
  • Integrin-Binding Sialoprotein / genetics
  • Integrin-Binding Sialoprotein / metabolism
  • Lung Neoplasms / drug therapy
  • Lung Neoplasms / genetics
  • Lung Neoplasms / metabolism*
  • Mesothelioma / drug therapy
  • Mesothelioma / genetics
  • Mesothelioma / metabolism*
  • Mesothelioma, Malignant
  • Mice
  • Neoplasm Transplantation
  • Osteoblasts / cytology*
  • Osteoblasts / metabolism
  • Osteogenesis* / drug effects
  • Osteonectin / metabolism

Substances

  • Biomarkers
  • Core Binding Factor Alpha 1 Subunit
  • Integrin-Binding Sialoprotein
  • Osteonectin
  • Dexamethasone
  • Alkaline Phosphatase